Integrated Core Strategies (US) LLC 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-16 4:52 pm Purchase | 2025-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Integrated Core Strategies (US) LLC | 162,884 2.800% | 84,704 (+108.34%) | Filing |
| 2024-08-14 4:07 pm Purchase | 2024-08-06 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Integrated Core Strategies (US) LLC | 78,180 5.200% | 78,180 (New Position) | Filing |